Tectonic Therapeutic, Inc. current report, 12 June 2023

Business Context and Reporting Period

This Form 8-K is filed by AVROBIO, Inc. (noting a discrepancy with the request metadata which listed "Tectonic Therapeutic, Inc.") on June 13, 2023, reporting events occurring on June 12, 2023. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Cambridge, MA. Its common stock trades on the Nasdaq Global Select Market under the symbol AVRO.

Key Financial Metrics

This filing is a Current Report regarding corporate governance and listing status. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial metric referenced is the stock price compliance threshold of $1.00 per share.

Material Changes

The material change reported is the resolution of a listing deficiency:

  • Previous Status: On May 11, 2023, Nasdaq notified the Company that its stock failed to maintain the minimum bid price of $1.00 per share for 30 consecutive business days (March 29, 2023, through May 10, 2023).
  • Current Status: On June 12, 2023, Nasdaq notified the Company that the closing bid price was at or above $1.00 per share for 14 consecutive business days (May 22, 2023, through June 9, 2023).
  • Outcome: The Company has regained compliance with Nasdaq Listing Rule 5450(a)(1), and the matter is closed.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on operations, or discussion of risks beyond the immediate resolution of the stock price compliance issue. No unusual items or contingencies are disclosed in this specific report.

Investor Verification Checklist

  • Verify the correct registrant name is AVROBIO, Inc. (AVRO), not Tectonic Therapeutic, Inc.
  • Confirm the current stock price remains above the $1.00 threshold to avoid future delisting notices.
  • Review the Company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K contains none.
  • Note the leadership structure: Erik Ostrowski serves as President, Interim CEO, CFO, and Treasurer.